"We are pleased to present the first report for our stakeholders describing infectious disease surveillance. High quality and timely surveillance is key to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for (including bacterial infections), investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk now or in the future."--Executive summary.
- Pages
- 16
- Published in
- Ottawa, Ontario
